rs217727 of lncRNA H19 is Associated with Cervical Cancer Risk in the Chinese Han Population

References

• Cohen PA, Jhingran A, Oaknin A, Denny L. Cervical cancer. Lancet. 2019;393(10167):169–182. doi:10.1016/S0140-6736(18)32470-X
   PubMed Web of Science ®Google Scholar
• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA a Cancer J Clin. 2021;71(3):209–249. doi:10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• Xu H, Lin A, Shao X, Shi W, Zhang Y, Yan W. Diagnostic accuracy of high-risk HPV genotyping in women with high-grade cervical lesions: evidence for improving the cervical cancer screening strategy in China. Oncotarget. 2016;7(50):83775–83783. doi:10.18632/oncotarget.11959
   PubMedGoogle Scholar
• Huang J, Deng Y, Boakye D, et al. Global distribution, risk factors, and recent trends for cervical cancer: a worldwide country-level analysis. Gynecol Oncol. 2022;164(1):85–92. doi:10.1016/j.ygyno.2021.11.005
   PubMed Web of Science ®Google Scholar
• Bhan A, Soleimani M, Mandal SS. Long noncoding RNA and cancer: a new paradigm. Cancer Res. 2017;77(15):3965–3981. doi:10.1158/0008-5472.CAN-16-2634
   PubMed Web of Science ®Google Scholar
• Aalijahan H, Ghorbian S. Long non-coding RNAs and cervical cancer. Exp Mol Pathol. 2019;106:7–16. doi:10.1016/j.yexmp.2018.11.010
   PubMed Web of Science ®Google Scholar
• Liu SJ, Dang HX, Lim DA, Feng FY, Maher CA. Long noncoding RNAs in cancer metastasis. Nat Rev Cancer. 2021;21(7):446–460. doi:10.1038/s41568-021-00353-1
   PubMed Web of Science ®Google Scholar
• Yao Z, Yang Y, Sun M, et al. New insights into the interplay between long non‐coding RNAs and RNA‐binding proteins in cancer. Cancer Commun. 2022;42(2):117–140. doi:10.1002/cac2.12254
   Web of Science ®Google Scholar
• Vitiello M, Tuccoli A, Poliseno L. Long non-coding RNAs in cancer: implications for personalized therapy. Cell Oncol. 2015;38(1):17–28. doi:10.1007/s13402-014-0180-x
   PubMed Web of Science ®Google Scholar
• Bartonicek N, Maag JLV, Dinger ME. Long noncoding RNAs in cancer: mechanisms of action and technological advancements. Mol Cancer. 2016;15(1):43. doi:10.1186/s12943-016-0530-6
   PubMed Web of Science ®Google Scholar
• Lian Y, Cai Z, Gong H, Xue S, Wu D, Wang K. HOTTIP: a critical oncogenic long non-coding RNA in human cancers. Mol BioSyst. 2016;12(11):3247–3253. doi:10.1039/C6MB00475J
   PubMedGoogle Scholar
• Zhu Z, Gao X, He Y, et al. An insertion/deletion polymorphism within RERT-lncRNA modulates hepatocellular carcinoma risk. Cancer Res. 2012;72(23):6163–6172. doi:10.1158/0008-5472.CAN-12-0010
   PubMed Web of Science ®Google Scholar
• Cui Z, Gao M, Yin Z, Yan L, Cui L. Association between lncRNA CASC8 polymorphisms and the risk of cancer: a meta-analysis. CMAR. 2018;10:3141–3148. doi:10.2147/CMAR.S170783
   Google Scholar
• Zheng Y, Lei T, Jin G, et al. LncPSCA in the 8q24.3 risk locus drives gastric cancer through destabilizing DDX5. EMBO Rep. 2021;22(11):e52707. doi:10.15252/embr.202152707
   PubMed Web of Science ®Google Scholar
• Betts JA, Moradi Marjaneh M, Al-Ejeh F, et al. Long noncoding RNAs CUPID1 and CUPID2 mediate breast cancer risk at 11q13 by modulating the response to DNA damage. Am J Hum Genet. 2017;101(2):255–266. doi:10.1016/j.ajhg.2017.07.007
   PubMed Web of Science ®Google Scholar
• McGeary SE, Lin KS, Shi CY, et al. The biochemical basis of microRNA targeting efficacy. Science. 2019;366(6472):eaav1741. doi:10.1126/science.aav1741
   PubMed Web of Science ®Google Scholar
• Novikova IV, Hennelly SP, Sanbonmatsu KY. Structural architecture of the human long non-coding RNA, steroid receptor RNA activator. Nucleic Acids Res. 2012;40(11):5034–5051. doi:10.1093/nar/gks071
   PubMed Web of Science ®Google Scholar
• Alzeer HS, Shaik JP, Reddy Parine N, et al. Genetic variants of HOTAIR associated with colorectal cancer: a case-control study in the Saudi Population. Genes. 2023;14(3):592. doi:10.3390/genes14030592
   PubMed Web of Science ®Google Scholar
• Cui P, Zhao Y, Chu X, et al. SNP rs2071095 in LincRNA H19 is associated with breast cancer risk. Breast Cancer Res Treat. 2018;171(1):161–171. doi:10.1007/s10549-018-4814-y
   PubMed Web of Science ®Google Scholar
• Abdi E, Latifi-Navid S, Zahri S, et al. SNP-SNP interactions of oncogenic long non-coding RNAs HOTAIR and HOTTIP on gastric cancer susceptibility. Sci Rep. 2020;10(1):16763. doi:10.1038/s41598-020-73682-0
   PubMed Web of Science ®Google Scholar
• Hu L, Chen S-H, Q-L L, et al. Clinical significance of long non-coding RNA CASC8 rs10505477 polymorphism in lung cancer susceptibility, platinum-based chemotherapy response, and toxicity. IJERPH. 2016;13(6):545. doi:10.3390/ijerph13060545
   Web of Science ®Google Scholar
• Li C, Li Y, Yan Z, et al. Polymorphisms in endoplasmic reticulum aminopeptidase genes are associated with cervical cancer risk in a Chinese Han population. BMC Cancer. 2020;20(1):341. doi:10.1186/s12885-020-06832-2
   PubMed Web of Science ®Google Scholar
• Chen K, Yan Z, Dong X, et al. Genetic polymorphisms in microRNA Genes Targeting PI3K/Akt signal pathway modulate cervical cancer susceptibility in a Chinese Population. Front Genet. 2022;13:856505. doi:10.3389/fgene.2022.856505
   PubMed Web of Science ®Google Scholar
• Yang J, Wang Y, Zhang S, et al. The association of TNF-α promoter polymorphisms with genetic susceptibility to cervical cancer in a Chinese Han Population. IJGM. 2022;15:417–427. doi:10.2147/IJGM.S350263
   Google Scholar
• Li Z, Zhang Z, He Z, et al. A partition-ligation-combination-subdivision EM algorithm for haplotype inference with multiallelic markers: update of the SHEsis (http://analysis.bio-x.cn). Cell Res. 2009;19(4):519–523.
   PubMed Web of Science ®Google Scholar
• Sole X, Guino E, Valls J, Iniesta R, Moreno V. SNPStats: a web tool for the analysis of association studies. Bioinformatics. 2006;22(15):1928–1929. doi:10.1093/bioinformatics/btl268
   PubMed Web of Science ®Google Scholar
• Dupont WD, Plummer WD. PS power and sample size program available for free on the internet. Control Clin Trials. 1997;18(3):274. doi:10.1016/S0197-2456(97)00074-3
   Google Scholar
• Qiu Y, Xu M, Huang S. Long noncoding RNAs: emerging regulators of normal and malignant hematopoiesis. Blood. 2021;138(23):2327–2336. doi:10.1182/blood.2021011992
   PubMed Web of Science ®Google Scholar
• Alvarez-Dominguez JR, Lodish HF. Emerging mechanisms of long noncoding RNA function during normal and malignant hematopoiesis. Blood. 2017;130(18):1965–1975. doi:10.1182/blood-2017-06-788695
   PubMed Web of Science ®Google Scholar
• Alvarez-Dominguez JR, Hu W, Gromatzky AA, Lodish HF. Long noncoding RNAs during normal and malignant hematopoiesis. Int J Hematol. 2014;99(5):531–541. doi:10.1007/s12185-014-1552-8
   PubMed Web of Science ®Google Scholar
• Alvarez-Dominguez JR, Hu W, Yuan B, et al. Global discovery of erythroid long noncoding RNAs reveals novel regulators of red cell maturation. Blood. 2014;123(4):570–581. doi:10.1182/blood-2013-10-530683
   PubMed Web of Science ®Google Scholar
• Cai X, Cullen BR. The imprinted H19 noncoding RNA is a primary microRNA precursor. RNA. 2007;13(3):313–316. doi:10.1261/rna.351707
   PubMed Web of Science ®Google Scholar
• Ghafouri-Fard S, Esmaeili M, Taheri M. H19 lncRNA: roles in tumorigenesis. Biomed Pharmacother. 2020;123:109774. doi:10.1016/j.biopha.2019.109774
   PubMed Web of Science ®Google Scholar
• Roychowdhury A, Samadder S, Das P, et al. Deregulation of H19 is associated with cervical carcinoma. Genomics. 2020;112(1):961–970. doi:10.1016/j.ygeno.2019.06.012
   PubMed Web of Science ®Google Scholar
• Feigenberg T, Gofrit ON, Pizov G, Hochberg A, Benshushan A. Expression of the H19 oncofetal gene in premalignant lesions of cervical cancer: a potential targeting approach for development of nonsurgical treatment of high-risk lesions. ISRN Obstet Gynecol. 2013;2013:1–7. doi:10.1155/2013/137509
   Google Scholar
• Iempridee T. Long non-coding RNA H19 enhances cell proliferation and Anchorage-independent growth of cervical cancer cell lines. Exp Biol Med. 2017;242(2):184–193. doi:10.1177/1535370216670542
   Web of Science ®Google Scholar
• Cáceres-Durán MÁ, Ribeiro-dos-Santos Â, Vidal AF. Roles and mechanisms of the long noncoding RNAs in cervical cancer. IJMS. 2020;21(24):9742. doi:10.3390/ijms21249742
   Google Scholar
• Wang X, Zhong J, Chen F, et al. Association between lncRNA H19 rs217727 polymorphism and the risk of cancer: an updated meta-analysis. BMC Med Genet. 2019;20(1):186. doi:10.1186/s12881-019-0904-x
   PubMed Web of Science ®Google Scholar
• Li L. Association between H19 SNP rs217727 and lung cancer risk in a Chinese population: a case control study. BMC Med Genet. 2018;19(1):1–6.
   PubMedGoogle Scholar
• Yang C, Tang R, Ma X, et al. Tag SNPs in long non-coding RNA H19 contribute to susceptibility to gastric cancer in the Chinese Han population. Oncotarget. 2015;6:15311–15320.
   PubMedGoogle Scholar
• Hua Q, Lv X, Gu X, et al. Genetic variants in lncRNA H19 are associated with the risk of bladder cancer in a Chinese population. Mutagenesis. 2016;31(5):531–538. doi:10.1093/mutage/gew018
   PubMed Web of Science ®Google Scholar
• Jin T, Wu X, Yang H, et al. Association of the miR-17-5p variants with susceptibility to cervical cancer in a Chinese population. Oncotarget. 2016;7(47):76647–76655. doi:10.18632/oncotarget.12299
   PubMedGoogle Scholar
• Huang M-C, Chou Y-H, Shen H-P, et al. The clinicopathological characteristic associations of long non-coding RNA gene H19 polymorphisms with uterine cervical cancer. J Cancer. 2019;10(25):6191–6198. doi:10.7150/jca.36707
   PubMed Web of Science ®Google Scholar
• Tan T, Li J, Wen Y, et al. Association between lncRNA- H19 polymorphisms and hepatoblastoma risk in an ethic Chinese population. J Cell Mol Med. 2021;25(2):742–750. doi:10.1111/jcmm.16124
   PubMed Web of Science ®Google Scholar
• Yuan Z, Yu Y, Zhang B, et al. Genetic variants in lncRNA H19 are associated with the risk of oral squamous cell carcinoma in a Chinese population. Oncotarget. 2018;9(35):23915–23922. doi:10.18632/oncotarget.23673
   PubMedGoogle Scholar
• Ge L, Wang Q, Hu S, Yang X. Rs217727 polymorphism in H19 promotes cell apoptosis by regulating the expressions of H19 and the activation of its downstream signaling pathway. J Cell Physiol. 2019;234(5):7279–7291. doi:10.1002/jcp.27485
   PubMed Web of Science ®Google Scholar
• Deng Y, Zhou L, Yao J, et al. Associations of lncRNA H19 polymorphisms at MicroRNA binding sites with glioma susceptibility and prognosis. Mol Ther Nucleic Acids. 2020;20:86–96. doi:10.1016/j.omtn.2020.02.003
   PubMedGoogle Scholar
• Matouk IJ, DeGroot N, Mezan S, et al. The H19 non-coding RNA is essential for human tumor growth. PLoS One. 2007;2(9):e845. doi:10.1371/journal.pone.0000845
   PubMed Web of Science ®Google Scholar
• Ghafouri-Fard S, Dashti S, Taheri M. The HOTTIP (HOXA transcript at the distal tip) lncRNA: review of oncogenic roles in human. Biomed Pharmacother. 2020;127:110158. doi:10.1016/j.biopha.2020.110158
   PubMed Web of Science ®Google Scholar
• Yang Y, Qian J, Xiang Y, Chen Y, Qu J. The prognostic value of long noncoding RNA HOTTIP on clinical outcomes in breast cancer. Oncotarget. 2017;8(4):6833–6844. doi:10.18632/oncotarget.14304
   PubMedGoogle Scholar
• Sun Y, Zeng C, Gan S, et al. LncRNA HOTTIP-mediated HOXA11 expression promotes cell growth, migration and inhibits cell apoptosis in breast cancer. IJMS. 2018;19(2):472. doi:10.3390/ijms19020472
   Google Scholar
• Zhang H, Zhao L, Wang Y-X, Xi M, Liu S-L, Luo -L-L. Long non-coding RNA HOTTIP is correlated with progression and prognosis in tongue squamous cell carcinoma. Tumor Biol. 2015;36:8805–8809.
   PubMedGoogle Scholar
• Hu P, Qiao O, Wang J, et al. rs1859168 A > C polymorphism regulates HOTTIP expression and reduces risk of pancreatic cancer in a Chinese population. World J Surg Onc. 2017;15(1):155. doi:10.1186/s12957-017-1218-0
   PubMedGoogle Scholar
• Duan F, Huang X, Shuang Z. Functional long non-coding RNAs associated with gastric cancer susceptibility and evaluation of the epidemiological efficacy in a central Chinese population. Cancer Medicine. 2018;7(4):1285–1296. doi:10.1002/cam4.1318
   PubMedGoogle Scholar
• Gong W-J, Yin J-Y, X-P L, et al. Association of well-characterized lung cancer lncRNA polymorphisms with lung cancer susceptibility and platinum-based chemotherapy response. Tumor Biol. 2016;37(6):8349–8358. doi:10.1007/s13277-015-4497-5
   PubMedGoogle Scholar
• Abdelaleem OO, Shaker OG, AbdelHafez MN, et al. The influence of rs1859168 polymorphism on serum expression of HOTTIP and its target miR-615-3p in Egyptian patients with breast cancer. Biomolecules. 2021;11(5):733. doi:10.3390/biom11050733
   PubMed Web of Science ®Google Scholar
• Qu X, Alsager S, Zhuo Y, Shan B. HOX transcript antisense RNA (HOTAIR) in cancer. Cancer Lett. 2019;454:90–97. doi:10.1016/j.canlet.2019.04.016
   PubMed Web of Science ®Google Scholar
• Silva RA, Ferreira MR, Gomes AM, Zambuzzi WF. LncRNA HOTAIR is a novel endothelial mechanosensitive gene. J Cell Physiol. 2020;235(5):4631–4642. doi:10.1002/jcp.29340
   PubMed Web of Science ®Google Scholar
• Xin X, Li Q, Fang J, Zhao T. LncRNA HOTAIR: a potential prognostic factor and therapeutic target in human cancers. Front Oncol. 2021;11:679244. doi:10.3389/fonc.2021.679244
   PubMedGoogle Scholar
• Sharma Saha S, Roy Chowdhury R, Mondal NR, et al. Identification of genetic variation in the lncRNA HOTAIR associated with HPV16-related cervical cancer pathogenesis. Cell Oncol. 2016;39(6):559–572. doi:10.1007/s13402-016-0298-0
   Web of Science ®Google Scholar
• Yang B, Gu B, Zhang J, Xu L, Sun Y. CASC8 lncRNA promotes the proliferation of retinoblastoma cells through downregulating miR34a methylation. CMAR. 2020;12:13461–13467. doi:10.2147/CMAR.S268380
   Google Scholar
• Wu Q, Zhang H, Yang D, et al. The m6A-induced lncRNA CASC8 promotes proliferation and chemoresistance via upregulation of hnRNPL in esophageal squamous cell carcinoma. Int J Biol Sci. 2022;18(13):4824–4836. doi:10.7150/ijbs.71234
   PubMed Web of Science ®Google Scholar
• Kim T, Cui R, Jeon Y-J, et al. Long-range interaction and correlation between MYC enhancer and oncogenic long noncoding RNA CARLo-5. Proc Natl Acad Sci USA. 2014;111(11):4173–4178. doi:10.1073/pnas.1400350111
   PubMed Web of Science ®Google Scholar
• Haerian M Sadat, Baum L, Haerian B Sadat. (2011). Association of 8q24.21 loci with the risk of colorectal cancer: a systematic review and meta-analysis. J Gastroenterol Hepatol, 26(10), 1475–84. 10.1111/j.1440-1746.2011.06831.x
   PubMed Web of Science ®Google Scholar
• Ma G et al . (2015). Genetic variant in 8q24 is associated with prognosis for gastric cancer in a Chinese population. J Gastroenterol Hepatol, 30(4), 689–95. 10.1111/jgh.12801
   PubMed Web of Science ®Google Scholar